109568
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
安布拉 1 缺乏通过 Akt-FoxO1-p27 通路抑制乳腺癌细胞增殖
Authors Qin Y, Chen S, Tao D, Lin Q, Sun W
Received 19 July 2025
Accepted for publication 15 October 2025
Published 21 October 2025 Volume 2025:17 Pages 949—965
DOI https://doi.org/10.2147/BCTT.S554928
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 4
Editor who approved publication: Professor Robert Clarke
Yanqiu Qin,* Siyu Chen,* Dongmei Tao, Qiulu Lin, Weiliang Sun
Department of Medical Oncology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Weiliang Sun, Department of Medical Oncology, The Second Affiliated Hospital of Guangxi Medical University, No. 166 East University Road, Nanning, Guangxi, 530007, People’s Republic of China, Tel/Fax +86-771-3277289, Email sunweiliang@stu.gxmu.edu.cn
Purpose: The unlimited proliferation of breast cancer (BC) cells is the basis for recurrence and metastasis. Ambra1 is involved in the regulation of cell proliferation, but its role may be cancer type-dependent, and the underlying mechanisms need further exploration. In addition, it remains unclear whether Ambra1 is involved in regulating the proliferation of BC cells. This study aims to explore the regulatory effect of Ambra1 on the proliferation of BC cells, as well as the underlying mechanisms.
Methods: The effects of Ambra1 on cell proliferation were detected in MCF-7 and MDA-MB-231 cells using CCK-8, EdU, and colony formation assays. The role of Ambra1 in regulating p27 via the Akt-FoxO1 pathway was determined in MCF-7, MDA-MB-231, and 293T cells through Western blotting, qRT-PCR, and co-immunoprecipitation. Subsequently, the role of p27 in Ambra1-mediated regulation of cell proliferation was validated in cell models and xenograft mouse models.
Results: Ambra1 deficiency significantly inhibited the proliferation of BC cells. p27 played a crucial role in this process. Furthermore, Ambra1 regulates the phosphorylation of the Ser256 residue of FoxO1 through Akt, thereby altering the nuclear distribution of FoxO1 and the transcription of p27.
Conclusion: Ambra1 can control the proliferation of BC cells by regulating the Akt-FoxO1-p27 signaling pathway. Therefore, this protein is a potential therapeutic target for BC.
Keywords: breast cancer, Ambra1, proliferation, p27, FoxO1, Akt
Department of Medical Oncology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Weiliang Sun, Department of Medical Oncology, The Second Affiliated Hospital of Guangxi Medical University, No. 166 East University Road, Nanning, Guangxi, 530007, People’s Republic of China, Tel/Fax +86-771-3277289, Email sunweiliang@stu.gxmu.edu.cn
Purpose: The unlimited proliferation of breast cancer (BC) cells is the basis for recurrence and metastasis. Ambra1 is involved in the regulation of cell proliferation, but its role may be cancer type-dependent, and the underlying mechanisms need further exploration. In addition, it remains unclear whether Ambra1 is involved in regulating the proliferation of BC cells. This study aims to explore the regulatory effect of Ambra1 on the proliferation of BC cells, as well as the underlying mechanisms.
Methods: The effects of Ambra1 on cell proliferation were detected in MCF-7 and MDA-MB-231 cells using CCK-8, EdU, and colony formation assays. The role of Ambra1 in regulating p27 via the Akt-FoxO1 pathway was determined in MCF-7, MDA-MB-231, and 293T cells through Western blotting, qRT-PCR, and co-immunoprecipitation. Subsequently, the role of p27 in Ambra1-mediated regulation of cell proliferation was validated in cell models and xenograft mouse models.
Results: Ambra1 deficiency significantly inhibited the proliferation of BC cells. p27 played a crucial role in this process. Furthermore, Ambra1 regulates the phosphorylation of the Ser256 residue of FoxO1 through Akt, thereby altering the nuclear distribution of FoxO1 and the transcription of p27.
Conclusion: Ambra1 can control the proliferation of BC cells by regulating the Akt-FoxO1-p27 signaling pathway. Therefore, this protein is a potential therapeutic target for BC.
Keywords: breast cancer, Ambra1, proliferation, p27, FoxO1, Akt